Icosavax
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Icosavax and buy or sell other stocks, ETFs, and their options commission-free!About ICVX
Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults.
CEOAdam K. Simpson
CEOAdam K. Simpson
Employees—
Employees—
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2017
Founded2017
Employees—
Employees—
ICVX Key Statistics
Market cap766.86M
Market cap766.86M
Price-Earnings ratio-6.89
Price-Earnings ratio-6.89
Dividend yield—
Dividend yield—
Average volume1.04M
Average volume1.04M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.11
52 Week high$16.11
52 Week low$4.75
52 Week low$4.75
Stock Snapshot
The current Icosavax(ICVX) stock price is $15.31, with a market capitalization of 766.86M. The stock trades at a price-to-earnings (P/E) ratio of -6.89.
On 2025-12-30, Icosavax(ICVX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Icosavax(ICVX) stock has reached 0, versus its average volume of 1.04M.
The stock's 52-week range extends from a low of $4.75 to a high of $16.11.
The stock's 52-week range extends from a low of $4.75 to a high of $16.11.
People also own
Based on the portfolios of people who own ICVX. This list is generated using Robinhood data, and it’s not a recommendation.